Framingham, MA, United States of America

Trinayan Kashyap

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovator Trinayan Kashyap: Pioneering Advances in Nuclear Transport Modulators

Introduction

Trinayan Kashyap, an accomplished inventor based in Framingham, MA, has made significant strides in the field of pharmaceutical innovations. With a total of four patents to his name, Kashyap is recognized for his groundbreaking work on nuclear transport modulators. His contributions are highly relevant in the treatment of disorders associated with CRM1 activity.

Latest Patents

Kashyap's latest patents focus on compounds of a specific formula, complemented by pharmaceutically acceptable salts. These innovations detail pharmaceutical compositions that utilize these compounds and their salts, offering methods for treating various disorders linked to CRM1 activity. The consistent theme of his work revolves around enhancing the therapeutic potential of nuclear transport modulators, which holds promise for future medical applications.

Career Highlights

Trinayan Kashyap's career has been marked by his tenure at Karyopharm Therapeutics Inc., a company known for its commitment to advancing treatments for cancer and other diseases. His work there exemplifies his dedication to developing solutions that address complex medical challenges. Through his innovative mindset, Kashyap has successfully translated scientific knowledge into practical therapeutic applications.

Collaborations

In his journey as an inventor, Trinayan has collaborated with notable colleagues, including Erkan Baloglu and Sharon Shacham. These professional partnerships have not only enriched his work but have also facilitated a dynamic exchange of ideas that drive innovation within the organization.

Conclusion

In conclusion, Trinayan Kashyap stands out as a key player in the realm of pharmaceutical science, particularly in the innovative development of nuclear transport modulators. His patents reflect a strong commitment to enhancing healthcare solutions and represent a valuable contribution to ongoing research in treating disorders related to CRM1 activity. As Kashyap continues his work, the potential impact of his inventions promises to advance medical therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…